Daily Roundup

PME.ASX VMM.ASX MCE.ASX C79.ASX CTQ.ASX

Pro Medicus Locks in Strong Contract Renewal

Pro Medicus has renewed its partnership with The Ohio State University Wexner Medical Center, securing a 5-year, A$16M contract for its imaging software solutions. The deal covers Visage 7 Workflow and Visage 7 Cardiology Imaging, and operates on a transaction-based model that could deliver additional upside. This renewal brings Pro Medicus's total contract renewals for the financial year to a robust A$141M, underscoring the company's ability to retain major clients in the competitive medical imaging space.

Viridis Advances Rare Earth Project with Grid Connection Deal

Viridis Mining and Minerals has inked its first major project execution contract, this time with Brazilian electricity distributor DME for critical power transmission infrastructure. The agreement covers a 3.2km, 138kV transmission line connecting the Colossus Rare Earth Project to the Brazilian grid, with an initial power allocation of 27MW for Stage 1 operations. The fixed-price package comes in at approximately BRL3.97 million (around US$0.8 million), giving Viridis cost certainty without exposure to construction escalation risks. With grid capacity secured from December 2027, the project is on track to support first production in the first half of 2028. The infrastructure is also being designed with capacity for future expansion up to 90MVA, keeping the door open for growth down the line.

Matrix Composites Moves Forward with Acquisition Vote

Matrix Composites & Engineering has cleared another hurdle in its proposed takeover by Advanced Innergy Solutions Australia Pty Ltd, with ASIC registering the Scheme Booklet. Shareholders now have the information they need to make an informed decision ahead of the Scheme Meeting on 6 July 2026. The Matrix board unanimously recommends voting in favor of the deal, and an independent expert has concluded the acquisition is fair and reasonable. The booklet is available on Matrix's website for shareholders to review.

Chrysos Lands $200M Facility to Fuel Expansion

Chrysos Corporation has successfully refinanced its corporate facilities with a new AUD$200 million three-year debt facility, backed by Australia and New Zealand Banking Group, National Australia Bank, and Export Finance Australia. The new deal improves on the company's previous terms with better pricing, lower commitment fees, and more favorable covenants. The facility will support production of 18 PhotonAssay units annually, with a forward order book already stretching to 22 units. Chrysos has signed 23 new lease agreements so far this year and recently hit a milestone of processing over one million samples for three consecutive months, riding a wave of strong gold market conditions and global adoption of its technology.

Careteq Simplifies Capital Structure with Convertible Note Conversion

Strategic investor Antanas Guoga has converted his convertible notes into ordinary shares at $0.01 per share, bringing 35.6 million new shares into circulation. The move simplifies Careteq's capital structure, eliminating all convertible notes and drawn debt facilities. Guoga's conversion signals confidence in the healthtech company's direction and its HMR Referrals platform, positioning Careteq to focus on growth without the complexity of outstanding convertible instruments hanging over the balance sheet.